| (210) | Number of the EPO application | 17728596 |
| (220) | Filing date of the EPO application | 2017.05.31 |
| (80) | EPO patent specification publication (B) | EPB nr. 24/2020, 2020.06.10 |
| (110) | EPO patent number | 3464309 |
| (21) | Number of the application | e 2019 0409 |
| (71) | Name(s) of applicant(s), code of the country | NuCana plc, GB; |
| (72) | Name(s) of inventor(s), code of the country | GRIFFITH Hugh, GB;
SERPI Michaela, GB;
SLUSARCZYK Magdalena, GB; |
| (73) | Name(s) of owner(s), code of the country | NUCANA plc, GB; |
| (54) | Title of the invention | PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07H 19/173 (2006.01.01); A61K 31/7076 (2006.01.01); C07H 19/207 (2006.01.01); A61P 35/00 (2006.01.01); A61P 35/02 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2019.05.31 |
| (30) | Priority | 201609601, 2016.06.01, GB |
| (86) | International application | PCT/GB2017/051549, 2017.05.31 |
| (87) | International publication | WO 2017/207986, 2017.12.07 |